Pediatric pharmacotherapy self assessment / Sandra Benavides, Hanna Phan, Milap C. Nahata ; contributors, Mary A. Babico [and twenty-one others].

Format:

Book

Author/Creator:

Benavides, Sandra, author.

Phan, Hanna, 1979- author.

Nahata, Milap C., author.

Contributor:

Babico,Mary A., contributor.

American Society of Health-System Pharmacists, publisher.

Language:

English

Subjects (All):

Pediatric pharmacology.

Physical Description:

1 online resource (285 p.)

Edition:

1st ed.

Place of Publication:

Bethesda, Maryland : ASHP Publications, 2015.

Language Note:

English

Summary:

A growing practice area, pediatric pharmacotherapy has been approved as a board-certified specialty. Yet, with little clinical data on the efficacy of drugs used for children and their other special needs, these small patients can be your biggest challenge.

Contents:

""titlepage""; ""table of contents""; ""contributors""; ""preface""; ""acknowledgments""; ""1.1 Pediatric Patient Care Management""; ""Part One - Cases""; ""CASE 2.1 Anaphylaxis | Level 1""; ""CASE 2.2 Nutrition | Level 2""; ""CASE 2.3 Toxicology | Level 3""; ""CASE 3.1 Patent Ductus Arteriosus | Level 1""; ""CASE 3.2 Hypertension | Level 2""; ""CASE 3.3 Congenital Heart Defects | Level 3""; ""CASE 4.1 Asthma | Level 1""; ""CASE 4.2 Cystic Fibrosis | Level 2""; ""CASE 4.3 Respiratory Distress Syndrome and Bronchopulmonary Dysplasia | Level 3""; ""CASE 5.1 Constipation | Level 1""

""CASE 5.2 Crohn Disease | Level 2""""CASE 6.1 Nephrotic Syndrome | Level 2""; ""CASE 6.2 Acute Kidney Injury | Level 3""; ""CASE 7.1 Type 2 Diabetes Mellitus | Level 1""; ""CASE 7.2 Hypothyroidism | Level 2""; ""CASE 7.3 Diabetic Ketoacidosis | Level 3""; ""CASE 8.1 Attention Deficit Hyperactivity Disorder | Level 1""; ""CASE 8.2 Autism Spectrum Disorder | Level 2""; ""CASE 8.3 Depression | Level 2""; ""CASE 8.4 Cerebral Palsy | Level 3""; ""CASE 8.5 Seizure Disorders | Level 3""; ""CASE 9.1 Acute Otitis Media | Level 1""; ""CASE 9.2 Skin and Skin Structure Infections | Level 1""

""CASE 9.3 Parasitic Infections | Level 2""""CASE 9.4 Pneumonia | Level 2""; ""CASE 9.5 Kawasaki Disease | Level 3""; ""CASE 9.6 Human Immunodeficiency Virus Infection | Level 3""; ""CASE 9.7 Meningitis | Level 3""; ""CASE 10.1 Anemia | Level 1""; ""CASE 10.2 Sickle Cell Disease | Level 2""; ""CASE 10.3 Anticoagulation | Level 3""; ""PART 2 | QUESTIONS & ANSWERS""; ""CASE 2.1 Anaphylaxis | Level 1""; ""CASE 2.2 Nutrition | Level 2""; ""CASE 2.3 Toxicology | Level 3""; ""CASE 3.1 Patent Ductus Arteriosus | Level 1""; ""CASE 3.2 Hypertension | Level 2""

""CASE 3.3 Congenital Heart Defects | Level 3""""CASE 4.1 Asthma | Level 1""; ""CASE 4.2 Cystic Fibrosis | Level 2""; ""CASE 4.3 Respiratory Distress Syndrome and Bronchopulmonary Dysplasia | Level 3""; ""CASE 5.1 Constipation | Level 1""; ""CASE 5.2 Crohn Disease | Level 2""; ""CASE 6.1 Nephrotic Syndrome | Level 2""; ""CASE 6.2 Acute Kidney Injury | Level 3""; ""CASE 7.1 Type 2 Diabetes Mellitus | Level 1""; ""CASE 7.2 Hypothyroidism | Level 2""; ""CASE 7.3 Diabetic Ketoacidosis | Level 3""; ""CASE 8.1 Attention Deficit Hyperactivity Disorder | Level 1""

""CASE 8.2 Autism Spectrum Disorder | Level 2""""CASE 8.3 Depression | Level 2""; ""CASE 8.4 Cerebral Palsy | Level 3""; ""CASE 8.5 Seizure Disorders | Level 3""; ""CASE 9.1 Acute Otitis Media | Level 1""; ""CASE 9.2 Skin and Skin Structure Infections | Level 1""; ""CASE 9.3 Parasitic Infections | Level 2""; ""CASE 9.4 Pneumonia | Level 2""; ""CASE 9.5 Kawasaki Disease | Level 3""; ""CASE 9.6 Human Immunodeficiency Virus Infection | Level 3""; ""CASE 9.7 Meningitis | Level 3""; ""CASE 10.1 Anemia | Level 1""; ""CASE 10.2 Sickle Cell Disease | Level 2""; ""CASE 10.3 Anticoagulation | Level 3""

""APPENDIXES""

Notes:

Description based upon print version of record.

Includes bibliographical references at the end of each chapters and index.

Description based on print version record.

ISBN:

1-58528-426-2

OCLC:

922966284